While a recent study has shown that intra-tumoral B cells in mTLS can generate and propagate plasma cells producing anti-tumor antibodies17, it remains unclear whether the induction of an anti-tumor CD8+ T cell response, which is most conducive to ICB treatment, can occur in the local TME, particularly at the TLS site. Here, CD8A is linked to neoplasm.